PETER HARRIS

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Oncotelic Therapeutics, Inc.

Filing Date Source Excerpt
2008-10-30 Peter Harris(5) Includes options to purchase 25,000 shares of common stock, which are exercisable through June 13, 2016.

Data sourced from SEC filings. Last updated: 2025-10-12